€0.10 ALCAR.PA Carmat SA Euronext 23 Mar 2026: Oversold bounce, watch volume

The ALCAR.PA stock is trading at €0.10 intraday on Euronext and shows a textbook oversold bounce setup. Price sits below the 50-day average (€0.15) and 200-day average (€0.59), but volume is slightly above average at 807,348 shares. For short-term traders the combination of depressed price, above-average volume, and clear support near the year low makes ALCAR.PA stock a candidate for a measured rebound trade while keeping tight risk limits.

ALCAR.PA stock: Intraday oversold bounce setup

Price is at €0.10 with a day range of €0.10–€0.11 and previous close €0.10. Volume at 807,348 is slightly above the 50-day average volume 797,166, supporting an intraday bounce thesis. The 50-day average price is €0.15, so intraday momentum would need to clear that level to validate a stronger recovery.

ALCAR.PA stock: Technical triggers and support levels

Immediate support sits near the year low €0.09 and the intraday low €0.10, which should limit downside for a short-term trade. Key resistances are the 50-day average €0.15 and the 200-day average €0.59; a sustained move above €0.15 would shift the bias toward a larger recovery. Traders should watch intraday volume and price action at €0.10–€0.15 for confirmation.

ALCAR.PA stock: Financials and valuation snapshot

Carmat shows trailing EPS -1.15 and a negative PE of -0.09, reflecting losses and a small market cap of €6,361,146.00. Price-to-sales is 0.91, current ratio is 1.70, and enterprise value is €59,458,146.00. These metrics show deep valuation stress but identify potential upside if commercial or clinical catalysts reappear.

ALCAR.PA stock: Meyka AI grade and model forecast

Meyka AI rates ALCAR.PA with a score of 72.74 out of 100 (Grade B+, BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month target of €0.35, implying an approximate 250.00% upside versus the current €0.10. Forecasts are model-based projections and not guarantees.

ALCAR.PA stock: Risks, catalysts and trading strategy

Main risks include continued cash burn, negative operating cash flow per share -1.90, and clinical or regulatory setbacks in the medical devices sector. Catalysts are improved procedure volumes or positive trial updates. For the oversold bounce strategy we recommend staged buys with a tight stop-loss below €0.09, position sizing under strict risk rules, and monitoring news and volume for confirmation.

Final Thoughts

ALCAR.PA stock is an intraday oversold bounce candidate at €0.10 on Euronext. Technical signals show price below both the 50-day (€0.15) and 200-day (€0.59) averages, while volume of 807,348 shares slightly exceeds the average 797,166, supporting a short-term rebound attempt. Meyka AI rates ALCAR.PA 72.74/100 (B+, BUY) after weighing sector comparison, financial growth, and market signals. Meyka AI’s forecast model projects a €0.35 12-month target, implying roughly 250.00% upside versus the current price; forecasts are model-based projections and not guarantees. Traders using the oversold bounce approach should use staged entries, a stop under €0.09, and watch news flow and intraday volume. For broader context consult the latest company earnings calendar and comparator views on Investing.com compare and the earnings schedule at Investing.com earnings calendar. Meyka AI provides this analysis as an AI-powered market analysis platform to help size risk and spot short-term setups.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.